Use of Biocellular and cellular approaches to treatment of Osteoarthritis (OA), musculoskeletal aging processes, pain, and degenerative changes are to be studied with minimally invasive protocols, and non-pharmaceutical means to relieve OA and its associated issues. Traditional surgical interventions have not yielded convincing long-term outcomes, including total joint replacement surgeries and medical management of the supportive structures.
This study is to use a person's own stem/stromal Cells (autologous) plus HD-PRP (important healing growth factors and signal molecules) in such cases of OA for long-term minimally invasive treatments. Baseline (existing) findings are documented, and thence tracked as to progress deemed to be result of the intervention.
Documented osteoarthritic inflammatory and/or degenerative changes in the joint or connective tissues of the knee, hip, shoulder, Achilles tendon, Sacroiliac Joint, wrist/hand, foot/ankle, or Plantar Fasciitis (PR);
No systemic disorders which, in opinion of principal investigator, would disqualify from safely being able to undergo the determined procedures;
Have the ability to understand and accept all items in Informed Consent Document;
Have adequate perivascular and extracellular matrix donor tissues available;
Systemic or psychological impairment which would preclude patient tolerance and understanding nature and extent of procedures and follow up tracking;
Known active cancer, chemotherapy, or radiation therapy;
Pregnancy;
Active infections which would increase risk of patient to undergo treatment;